Amitriptyline hydrochloride/Perphenazine

盐酸阿米替林/奋乃静

Report date: 2022/03/07 18:02:23
NME

Base Information

Drug NameAmitriptyline hydrochloride/Perphenazine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionMonoamine reuptake inhibitorDopamine D2 receptor antagonists
TargetsMonoamine transportersDopamine D2 receptor
Therapy Area/IndicationsAnxiety Disorders
Global Approved IndicationsAnxiety Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date1963/01/01
Country/TerritoryCanadaUnited States
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSchering Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksN/A